LBel

Manufacturer: VENTURA INTERNATIONAL LTD.,
Effective date: 2010-08-10
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: legacy-cache
Hydrated at: 2026-08-02 01:52:35

Label at a glance#

ProductLBel Effet Parfait Rouge Alissant

Active ingredientOctinoxate, Oxybenzone

Label structure9 sections

Indications and uses

Helps prevent sunburn. Moderate sun protection product.

Dosage and administration

Apply evenly before sun exposure and as needed. Apply lipstick following the curves of natural lip line.For added definition, use with a lip pencil.

Storage and handling

Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risk of skin cancer, and other harmful effects of the sun.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Octinoxate (6.0 %), Oxybenzone (1.5 %).

Purpose

OTC - PURPOSE SECTION

Sunscreen

Uses

INDICATIONS & USAGE SECTION

Helps prevent sunburn. Moderate sun protection product.

Warnings

WARNINGS SECTION

OTC - STOP USE SECTION

Stop use if skin rash occurs.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply evenly before sun exposure and as needed. Apply lipstick following the curves of natural lip line.For added definition, use with a lip pencil.

Other information

STORAGE AND HANDLING SECTION

Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risk of skin cancer, and other harmful effects of the sun.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Methyl hydrogenated rosinate, diisopropyl dimer dilinoleate, myristyl myristate,myristyl myristate, castor isostearate beeswax succinate, cera alba (beeswax), copernicia cerifera(carnauba) wax, disteardimonium hectorite, dipalmitoyl hydroxyproline, silica silylate, octyldodecanol, menthoxypropanediol, cera microcristallina (microcrystalline wax), propylparaben, methylparaben, parfum (fragance), petrolatum, phospholipids, bht, cholesterol, polyglyceryl-2 dipolyhydroxystearate, euphorbia cerifera (candelilla) wax, cetearyl glucoside, cetearyl alcohol, glycosphingolipids. May contain: ci 77019 (mica), ci 77891 (titanium dioxide), ci 77491, ci 77492, ci 77499 (iron oxides), silica, ci 75470 (carmine), calcium aluminum borosilicate, tin oxide, ricinus communis (castor) seed oil, ci 42090 (blue 1 lake), talc, ci 15850:1 (red 7 lake), ci 19140 (yellow 5 lake), ci 45380:2 (red 21 lake), ci 45410:1 (red 27 lake).

SPL UNCLASSIFIED SECTION

US: Distributed by Ventura International, Ltd. San Francisco, CA 94111

PRINCIPAL DISPLAY PANEL - 4 g Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

EFFET PARFAIT
ROUGE ALISSANT

lipstick wrinkle minimizer effect spf 17

4 g e (.14 oz.)

L'BEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
13537-011-62	2025-02-19	C162847	48780-1	956f9ecf-c9c6-621f-e053-dbdaa90a74ad	L'BEL Effet Parfait Rouge Alissant SPF17
13537-011-62	2019-10-21	C162847	48780-1	956f9ecf-c9c6-621f-e053-dbdaa90a74ad	L'BEL Effet Parfait Rouge Alissant SPF17

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Octinoxate	ACTIVE INGREDIENT	4Y5P7MUD51	1
Oxybenzone	ACTIVE INGREDIENT	95OOS7VE0Y	1
Octinoxate	ACTIVE MOIETY	4Y5P7MUD51	1
Oxybenzone	ACTIVE MOIETY	95OOS7VE0Y	1
aluminum oxide	INACTIVE INGREDIENT	LMI26O6933	1
butylated hydroxytoluene	INACTIVE INGREDIENT	1P9D0Z171K	1
candelilla wax	INACTIVE INGREDIENT	WL0328HX19	1
carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	1
castor oil	INACTIVE INGREDIENT	D5340Y2I9G	1
cetostearyl alcohol	INACTIVE INGREDIENT	2DMT128M1S	1
cholesterol	INACTIVE INGREDIENT	97C5T2UQ7J	1
D&C RED NO. 21	INACTIVE INGREDIENT	08744Z6JNY	1
D&C RED NO. 27	INACTIVE INGREDIENT	2LRS185U6K	1
D&C RED NO. 7	INACTIVE INGREDIENT	ECW0LZ41X8	1
dipalmitoyl hydroxyproline	INACTIVE INGREDIENT	E6AHA53N1H	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	1
FD&C YELLOW NO. 5	INACTIVE INGREDIENT	I753WB2F1M	1
ferric oxide red	INACTIVE INGREDIENT	1K09F3G675	1
ferric oxide yellow	INACTIVE INGREDIENT	EX438O2MRT	1
ferrosoferric oxide	INACTIVE INGREDIENT	XM0M87F357	1
hectorite	INACTIVE INGREDIENT	08X4KI73EZ	1
methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	1
mica	INACTIVE INGREDIENT	V8A1AW0880	1
myristyl myristate	INACTIVE INGREDIENT	4042ZC00DY	1
octyldodecanol	INACTIVE INGREDIENT	461N1O614Y	1
petrolatum	INACTIVE INGREDIENT	4T6H12BN9U	1
propylparaben	INACTIVE INGREDIENT	Z8IX2SC1OH	1
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
talc	INACTIVE INGREDIENT	7SEV7J4R1U	1
tin	INACTIVE INGREDIENT	387GMG9FH5	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	1
yellow wax	INACTIVE INGREDIENT	2ZA36H0S2V	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 32 matching rows.

LBel Effet Parfait Rouge Alissant
Octinoxate and Oxybenzone
Octinoxate
Oxybenzone
myristyl myristate
yellow wax
carnauba wax
hectorite
dipalmitoyl hydroxyproline
silicon dioxide
octyldodecanol
propylparaben
methylparaben
petrolatum
butylated hydroxytoluene
cholesterol
candelilla wax
cetostearyl alcohol
mica
titanium dioxide
ferric oxide red
ferric oxide yellow
ferrosoferric oxide
tin
castor oil
FD&C BLUE NO. 1
aluminum oxide
talc
D&C RED NO. 7
FD&C YELLOW NO. 5
D&C RED NO. 21
D&C RED NO. 27

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
13537-011	13537-011-61, 13537-011-62

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 30 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Octinoxate	4Y5P7MUD51	ACTIB
Oxybenzone	95OOS7VE0Y	ACTIB
myristyl myristate	4042ZC00DY	IACT
yellow wax	2ZA36H0S2V	IACT
carnauba wax	R12CBM0EIZ	IACT
hectorite	08X4KI73EZ	IACT
dipalmitoyl hydroxyproline	E6AHA53N1H	IACT
silicon dioxide	ETJ7Z6XBU4	IACT
octyldodecanol	461N1O614Y	IACT
propylparaben	Z8IX2SC1OH	IACT
methylparaben	A2I8C7HI9T	IACT
petrolatum	4T6H12BN9U	IACT
butylated hydroxytoluene	1P9D0Z171K	IACT
cholesterol	97C5T2UQ7J	IACT
candelilla wax	WL0328HX19	IACT
cetostearyl alcohol	2DMT128M1S	IACT
mica	V8A1AW0880	IACT
titanium dioxide	15FIX9V2JP	IACT
ferric oxide red	1K09F3G675	IACT
ferric oxide yellow	EX438O2MRT	IACT
ferrosoferric oxide	XM0M87F357	IACT
tin	387GMG9FH5	IACT
castor oil	D5340Y2I9G	IACT
FD&C BLUE NO. 1	H3R47K3TBD	IACT
aluminum oxide	LMI26O6933	IACT
talc	7SEV7J4R1U	IACT
D&C RED NO. 7	ECW0LZ41X8	IACT
FD&C YELLOW NO. 5	I753WB2F1M	IACT
D&C RED NO. 21	08744Z6JNY	IACT
D&C RED NO. 27	2LRS185U6K	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 9 · 512 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
propylparaben	PROPYLPARABEN	Z8IX2SC1OH	CREAM, AUGMENTED / TOPICAL		2 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	CAPSULE, COATED PELLETS / ORAL	14 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	SUSPENSION / ORAL		6 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION/ DROPS / OPHTHALMIC	0.05 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
cetostearyl alcohol	CETOSTEARYL ALCOHOL	2DMT128M1S	TABLET, EXTENDED RELEASE / ORAL		800 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
propylparaben	PROPYLPARABEN	Z8IX2SC1OH	TABLET, COATED / ORAL	0.8 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
castor oil	CASTOR OIL	D5340Y2I9G	EMULSION / OPHTHALMIC		32 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
candelilla wax	CANDELILLA WAX	WL0328HX19	TABLET, EXTENDED RELEASE / ORAL		3 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	SOLUTION / RECTAL	0.01 %w/v		Exact identifier — unii candidate 37 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	DROPS / NASAL	26 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
FD&C YELLOW NO. 5	FD&C YELLOW NO. 5	I753WB2F1M	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 22 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, EXTENDED RELEASE / ORAL		15 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
petrolatum	PETROLATUM	4T6H12BN9U	LIQUID / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / BUCCAL		3 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	TABLET, CHEWABLE / ORAL		202 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
octyldodecanol	OCTYLDODECANOL	461N1O614Y	FILM / TRANSDERMAL	32.44 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
propylparaben	PROPYLPARABEN	Z8IX2SC1OH	INJECTION / SOFT TISSUE	0.02 %w/v		Exact identifier — unii candidate 68 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION / ORAL		200 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, EXTENDED RELEASE / ORAL		450 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
petrolatum	PETROLATUM	4T6H12BN9U	CAPSULE, EXTENDED RELEASE / ORAL	0.07 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, CHEWABLE / ORAL		14 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
carnauba wax	CARNAUBA WAX	R12CBM0EIZ	CAPSULE, EXTENDED RELEASE / ORAL		288 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
propylparaben	PROPYLPARABEN	Z8IX2SC1OH	TABLET, CHEWABLE / ORAL	0.14 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	JELLY / NASAL	250 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
propylparaben	PROPYLPARABEN	Z8IX2SC1OH	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 68 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, DELAYED RELEASE / ORAL	3.2 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	POWDER, FOR SUSPENSION / ORAL		297 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	CAPSULE, EXTENDED RELEASE / ORAL	0.03 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	POWDER, FOR SUSPENSION / ORAL	1 mg/5ml		Exact identifier — unii candidate 37 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / RESPIRATORY (INHALATION)	0.03 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	OINTMENT / TOPICAL		57 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
petrolatum	PETROLATUM	4T6H12BN9U	CREAM / TOPICAL		4213 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
propylparaben	PROPYLPARABEN	Z8IX2SC1OH	ENEMA / RECTAL	0.02 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	SOAP / TOPICAL	1 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	GEL / TOPICAL		24 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
cholesterol	CHOLESTEROL	97C5T2UQ7J	CREAM / TOPICAL	1 %w/w		Exact identifier — unii candidate 10 equally ranked IID candidates
candelilla wax	CANDELILLA WAX	WL0328HX19	TABLET, DELAYED RELEASE / ORAL		1 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 32 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	PELLET / ORAL		34 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / ORAL		346 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / SUBCUTANEOUS	0.16 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	GRANULE, FOR SUSPENSION / ORAL		296 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
petrolatum	PETROLATUM	4T6H12BN9U	SPONGE / TOPICAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	FILM, SOLUBLE / ORAL		2 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / TOPICAL		216 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
talc	TALC	7SEV7J4R1U	SUSPENSION / ORAL		234 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
cholesterol	CHOLESTEROL	97C5T2UQ7J	LOTION / TOPICAL		20 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	DROPS / OPHTHALMIC	0.01 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	DOUCHE / VAGINAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
castor oil	CASTOR OIL	D5340Y2I9G	CAPSULE, EXTENDED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 16 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, FILM COATED / ORAL	0.2 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, EXTENDED RELEASE / ORAL		168 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
octyldodecanol	OCTYLDODECANOL	461N1O614Y	SYSTEM / TRANSDERMAL	4.05 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
propylparaben	PROPYLPARABEN	Z8IX2SC1OH	CAPSULE, EXTENDED RELEASE / ORAL	0.22 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
propylparaben	PROPYLPARABEN	Z8IX2SC1OH	FILM / BUCCAL	0.22 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
FD&C YELLOW NO. 5	FD&C YELLOW NO. 5	I753WB2F1M	TABLET / SUBLINGUAL	0.11 mg		Exact identifier — unii candidate 22 equally ranked IID candidates
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	CAPSULE / ORAL	26.3 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
petrolatum	PETROLATUM	4T6H12BN9U	OINTMENT / VAGINAL		4084 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
castor oil	CASTOR OIL	D5340Y2I9G	SPRAY / NASAL	NA		Exact identifier — unii candidate 16 equally ranked IID candidates
castor oil	CASTOR OIL	D5340Y2I9G	INJECTION, SOLUTION / INTRAMUSCULAR		525 mg	Exact identifier — unii candidate 16 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
2e71d200-aa6d-85ff-e063-6394a90a93fa			37196036-229e-4061-8379-cf440b15275c	2025-02-18	Warnings	Exact identifier spl set id: 37196036-229e-4061-8379-cf440b15275c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.